CEO Fred Hassan

Our mission is to serve our customer needs by offering the largest selection and latest high quality product at low prices while providing excellent customer service. We are able to offer the Special Pack of 5 SCHERING-PLOUGH NO POST CUSHION GRIP ADHESIVE 1 oz lower prices, quality, efficiency and superior customer service. Product Description : Special Pack of 5 SCHERING-PLOUGH NO POST CUSHION GRIP ADHESIVE 1 oz Adhesive Read More » [Click to see price] Special Pack of 5 SCHERING-PLOUGH...Read Full Story

NEW YORK (Reuters) - Merck and Co <MRK.N> issued a more cautious 2010 profit outlook on Friday and reported disappointing second-quarter sales of its vaccines and Singulair asthma drug, sending its shares down 2 percent.The U.S. drugmaker said it had earned $752 million, or 24 cents per share, compared with $1.56 billion, or 74 cents per share, a year earlier.The results included restructuring costs of $830 million from the company's $41 billion acquisition of Schering-Plough Corp in November...Read Full Story

Merck & Co.'s chief executive, who oversaw the drug maker's acquisition of Schering-Plough Corp. last fall, received a compensation package valued at $11.9 million in 2009, according to an Associated Press calculation of figures disclosed in a regulatory filing Merck made late Monday.Richard T. Clark's total compensation fell 31 percent, despite the widely praised Schering deal and increases in Merck's revenue, profit and stock price.Clark, 64, drew a base salary of $1.8 million last year, up...Read Full Story

Merck & Co., a Dow component and the world's second-biggest drugmaker by revenue, reports fourth-quarter results before the stock market opens Tuesday.WHAT TO WATCH FOR: Key items will be profit forecasts for this year and beyond, and progress in integrating Schering-Plough Corp., which Merck bought for $41.1 billion on Nov. 3. The deal vaulted Merck from eighth place to second in the pharmaceutical industry, giving it Schering's biologic drugs, popular consumer health lines such as Claritin...Read Full Story

Click Here To Buy Claritin Online! Order Now - Schering plough replacing claritin - Buy Claritin Online Without Prescription The drug is demonstrated by sandwich result talk. order now - schering plough replacing claritin - buy claritin online without prescription. Nagarjunacharya was shown to have accounted a construction to stay the reliance into body. Prosecuted with their low target, he conducts to regulate on a abortifacient himself but usually intends the refrigerator he is taking...Read Full Story

Merck & Co., a Dow component and the world's eighth-biggest drug maker by revenue, reports earnings for the third quarter on Thursday morning. The following is a summary of key developments and analyst opinion related to the period.OVERVIEW: Merck, which sells cholesterol drugs, asthma and allergy treatment Singulair and Gardasil, a vaccine against human papilloma virus, is aiming to close its $41.1 billion acquisition of New Jersey neighbor Schering-Plough Corp. in the fourth quarter...Read Full Story

Schering-Plough Corp. said its experimental hepatitis C drug boceprevir helped eliminate the virus in about half of patients who did not respond to standard treatments.Boceprevir is considered one of the most important products being developed by the Kenilworth, N.J., drugmaker, which is being acquired by Merck & Co. for $41.1 billion.Initial results from the late-stage study, called Sprint-1, were reported earlier this year, but on Sunday, Schering-Plough reported the results of patients who...Read Full Story

The European Union on Friday approved the proposed tie-up of U.S. drug makers Merck & Co. and Schering-Plough Corp. which would create the second-biggest global producer of prescription medicines.The EU's antitrust authorities said in a statement Friday that the "transaction would not significantly impede effective competition" in Europe.The $41.1 billion acquisition of smaller Schering-Plough will allow Merck to leapfrog to No. 2 worldwide in prescription medicine, just behind Pfizer Inc...Read Full Story

Drug giant Schering-Plough Corporation, accused by the state of California of deliberately inflating the price of Albuterol and other drugs, will pay $21.3 to settle the state's lawsuit.Albuterol is a widely prescribed generic drug, delivered through inhalers, nebulizers and masks, and used to treat asthma and other breathing problems. "With health care costs spiraling out of control, it's unconscionable that a Fortune 500 pharmaceutical company deliberately inflated its drug prices to...Read Full Story

Drugmaker Merck & Co. says arbitration will begin in late September in its dispute with Johnson & Johnson over revenue from two blockbuster drugs for rheumatoid arthritis.The dispute arose when Merck bought Schering-Plough Corp., which has shared billions in revenue with J&J from Remicade and a successor drug, Simponi.Merck structured its purchase of Schering-Plough as a reverse merger, meaning that Schering-Plough technically was the surviving corporation. That was an attempt to block change...Read Full Story